logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12653821 B1

PDFFull Text
Date of Patent:
Jun. 16, 2026

Filed:

Aug. 26, 2021

Cariprazine pharmaceutical composition, preparation method and application thereof

Applicant:

Shanghai Bocimed Pharmaceutical Co., Ltd., Shanghai, CN;

Inventors:

Shuhuan Ying, Shanghai, CN;

Zhixiang Chen, Shanghai, CN;

Xian Zhang, Shanghai, CN;

Tao Zhu, Shanghai, CN;

Tingting Wang, Shanghai, CN;

Assignee:

SHANGHAI BOCIMED PHARMACEUTICAL CO., LTD., Shanghai, CN;

Attorneys:

NKL Law

Allen Xue

Primary Examiner:

Ali Soroush

Assistant Examiner:

Samantha J Knight

Int. Cl.
CPC ...
A61K 31/495 (2006.01); A61K 9/00 (2006.01); A61K 47/02 (2006.01); A61K 47/26 (2006.01); A61K 47/38 (2006.01); A61K 9/10 (2006.01);
U.S. Cl.
CPC ...
A61K 31/495 (2013.01); A61K 9/0019 (2013.01); A61K 47/02 (2013.01); A61K 47/26 (2013.01); A61K 47/38 (2013.01); A61K 9/10 (2013.01); C07B 2200/13 (2013.01);
Abstract

A pharmaceutical composition containing cariprazine, a preparation method and an application thereof are provided. The pharmaceutical composition contains cariprazine pamoate solid particles. A particle size of the cariprazine solid particles has a Dv(10) less than or equal to 30 microns, a Dv(50) less than or equal to 50 microns, and a Dv(90) less than or equal to 100 microns. When being used, the pharmaceutical composition containing cariprazine is an aqueous suspension and the concentration of the free base of cariprazine is moderate. A long-term effect can be achieved upon injection of a certain administration volume of the pharmaceutical composition, thereby reducing the frequency of medication while increasing patient medication compliance. Furthermore, the pharmaceutical composition has a high bioavailability and has promising marketing prospects.

Find Patent Forward Citations

Ying, Shuhuan. (2026). Cariprazine pharmaceutical composition, preparation method and application thereof (U.S. Patent No. 12653821). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12653821

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…